【鉄門だより:2013年5月号より】 :
【略歴】 川端英孝
1963年愛媛県生まれ
1988年東大医学部卒業。東大病院およびその関連病院を経て
1997年東大病院第2外科助手
1998年JR東京総合病院外科医長
2006年虎の門病院乳腺内分泌外科部長〜現在に至る。
2011年より東大医学部非常勤講師を兼任
これまに3000名の乳癌患者さんの手術,治療を担当


【資格、役職等】 日本外科学会専門医、指導医 日本乳癌学会専門医、指導医、臨床研指導医 がん治療認定医、マンモグラフィー読影認定医AS  ASCO active member 日本乳癌学会評議員 日本リンパ浮腫治療学会評議員 日本乳癌学会:倫理委員会委員、研究倫理審査小委員会委員長、教育・研修委員会委員、認定委員会委員・関東地区委員長 International Cancer Conference Journal査読委員 Cancer Science査読委員 JBCRG (Japan Breast Cancer Research Group)理事 2019年日本乳癌学会総会プログラム委員長                                     

【業績等】

Breast. 2018 Apr 23;40:67-75.

A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP.

Takano T, Tsurutani J, Takahashi M, Yamanaka T, Sakai K, Ito Y, Fukuoka J, Kimura H, Kawabata H, Tamura K, Matsumoto K, Aogi K, Sato K, Nishio K, Nakagawa K, Saeki T.

 

 

Asia Pac J Clin Oncol. 2018 Mar 1. doi: 10.1111/ajco.12863

A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane-based regimens.

Kikuchi Y, Uchida Y, Shirakawa K, Kanauchi H, Niwa T, Nishioka K, Tada K, Hashimoto M, Yasuda H, Sugiura R, Kawabata H, Seto Y, Ogawa T.

 

Breast Cancer. 2018 May;25(3):343-349

Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.

Ozaki Y, Tanabe Y, Tamura N, Ogura T, Kondoh C, Miura Y, Yoshimura K, Kawabata H, Takano T.

 

Int J Mol Sci. 2017 Sep 8;18(9). pii: E1931.

Hidetaka Kawabata, Kotaro Azuma, Kazuhiro Ikeda, Ikuko Sugitani, Keiichi Kinowaki, Takeshi Fujii, Akihiko Osaki, Toshiaki Saeki, Kuniko Horie-Inoue, Satoshi Inoue  

TRIM44 is a poor prognostic factor for breast cancer patients as a modulator of NF-κB signaling

 

 

Cancer Chemother Pharmacol. 2017 Jun;79(6):1179-1186

Tanabe Y, Shimizu C, Hamada A, Hashimoto K, Ikeda K, Nishizawa D, Hasegawa J, Shimomura A, Ozaki Y, Tamura N, Yamamoto H, Yunokawa M, Yonemori K, Takano T, Kawabata H, Tamura K, Fujiwara Y. 

Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.   

 

Breast Cancer Res Treat. 2014 May;145(1):143-53
Takada M, Ishiguro H, Nagai S, Ohtani S,
Kawabata H, Yanagita Y, Hozumi Y, Shimizu C, Takao S, Sato N, Kosaka Y, Sagara Y, Iwata H, Ohno S, Kuroi K, Masuda N, Yamashiro H, Sugimoto M, Kondo M, Naito Y, Sasano H, Inamoto T, Morita S, Toi M.  

Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study).

The Breast 2014 August 23(4) 466-72 
Maki Tanioka, Masaoki Sasaki, Akihiko Shimomura, Makoto Fujishima, Mihoko Doi, Kazuo Matsuura, Toshiko Sakuma, Kenichi Yoshimura, Toshiaki Saeki, Masahiro Ohara, Junji Tsurutani,Masahiro Watatani, Toshimi Takano,
Hidetaka Kawabata, Hirofumi Mukai, Yoichi Naito, Koichi Hirokaga, Shintaro Takao and Hironobu Minami   
Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status

Chemotherapy 2013; 59(2):93-98
Marie Hanaoka,
Hidetaka Kawabata, Tsuguo Iwatani, Toshimi Takano, Daishu Miura    
Reduction of Toxicity by Reversing the Order of Infusion of Docetaxel and Cyclophosphamide.

J Cancer  2013  4:519-523

Miura Y, Theriault RL, Naito Y, Suyama K, Shimomura A, Iwatani T, Miura D, Kawabata H, Kumada H, and Takano T:

The safety of chemotherapy for breast cancer patients with hepatitis C virus infection.

 

Psycho-Oncology 2012 (Article first published online:DOI: 10.1002/pon.3023)

Tsuguo Iwatani, Ayako Matsuda, Hidetaka Kawabata, Daishu Miura, Eisuke Matsushima    

Predictive factors for psychological distress related to diagnosis of breast cancer.

J.Clin.Oncol 2011,29, e113-115
Tsuguo Iwatani,
Hidetaka Kawabata, Daishu Miura, Yasunori Ota, Kenichi Ohashi     Complete Spontaneous Regression of Primary Diffuse Large B-cell Lymphoma of the Breast

N Engl J Med 2011;365:1056-7
Marie Hanaoka, Toshimi Takano,
Hidetaka Kawabata (Comment on: N Engl J Med 2011; 364: 2381-2391)
Exemestane for Breast-Cancer Prevention.

Breast Cancer, 2009, DOI 10.1007/s12282-009-0149-1
Tsuguo Iwatani,
Hidetaka Kawabata, Daishu Miura, Naoko Inoshita, Yasunori Ohta
Nodular fasciitis of the breast.

Lancet 2001,358,1018
Hidetaka Kawabata, Takafumi Ueno
Screening recommendation for women taking tamoxifen

Lancet 2000,355,238
Takafumi Ueno、
Hidetaka Kawabata
Tobacco and health care professionals in Japan

Lancet 1999,354,1207
Hidetaka Kawabata,Takafumi Ueno
Early Lung Cancer Action Project.

Lancet 1999,353,2077
Hidetaka Kawabata,Takafumi Ueno
Controversy over cancer chemotherapy in Japan

Acta Cytologica 1998,42, 708-15
Preparation of Heat-Labile Antigens on Air-Dried Cytologic Specimens for Immunocytochemical Analysis
Noriyuki Baba,
Hidetaka Kawabata, Takayuki Kanno, Takafumi Ueno, and Masatoshi Makuuchi



トップページに戻る: